Cargando…
Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors
The mechanisms underlying pathophysiological regulation of tissue macrophage (Mφ) subsets remain poorly understood. From the expression of 207 Mφ genes comprising 31 markers for 10 subsets, 45 transcription factors (TFs), 56 immunometabolism enzymes, 23 trained immunity (innate immune memory) enzyme...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880770/ https://www.ncbi.nlm.nih.gov/pubmed/31824480 http://dx.doi.org/10.3389/fimmu.2019.02612 |
_version_ | 1783473826736111616 |
---|---|
author | Lai, Bin Wang, Jiwei Fagenson, Alexander Sun, Yu Saredy, Jason Lu, Yifan Nanayakkara, Gayani Yang, William Y. Yu, Daohai Shao, Ying Drummer, Charles Johnson, Candice Saaoud, Fatma Zhang, Ruijing Yang, Qian Xu, Keman Mastascusa, Kevin Cueto, Ramon Fu, Hangfei Wu, Susu Sun, Lizhe Zhu, Peiqian Qin, Xuebin Yu, Jun Fan, Daping Shen, Ying H. Sun, Jianxin Rogers, Thomas Choi, Eric T. Wang, Hong Yang, Xiaofeng |
author_facet | Lai, Bin Wang, Jiwei Fagenson, Alexander Sun, Yu Saredy, Jason Lu, Yifan Nanayakkara, Gayani Yang, William Y. Yu, Daohai Shao, Ying Drummer, Charles Johnson, Candice Saaoud, Fatma Zhang, Ruijing Yang, Qian Xu, Keman Mastascusa, Kevin Cueto, Ramon Fu, Hangfei Wu, Susu Sun, Lizhe Zhu, Peiqian Qin, Xuebin Yu, Jun Fan, Daping Shen, Ying H. Sun, Jianxin Rogers, Thomas Choi, Eric T. Wang, Hong Yang, Xiaofeng |
author_sort | Lai, Bin |
collection | PubMed |
description | The mechanisms underlying pathophysiological regulation of tissue macrophage (Mφ) subsets remain poorly understood. From the expression of 207 Mφ genes comprising 31 markers for 10 subsets, 45 transcription factors (TFs), 56 immunometabolism enzymes, 23 trained immunity (innate immune memory) enzymes, and 52 other genes in microarray data, we made the following findings. (1) When 34 inflammation diseases and tumor types were grouped into eight categories, there was differential expression of the 31 Mφ markers and 45 Mφ TFs, highlighted by 12 shared and 20 group-specific disease pathways. (2) Mφ in lung, liver, spleen, and intestine (LLSI-Mφ) express higher M1 Mφ markers than lean adipose tissue Mφ (ATMφ) physiologically. (3) Pro-adipogenic TFs C/EBPα and PPARγ and proinflammatory adipokine leptin upregulate the expression of M1 Mφ markers. (4) Among 10 immune checkpoint receptors (ICRs), LLSI-Mφ and bone marrow (BM) Mφ express higher levels of CD274 (PDL-1) than ATMφ, presumably to counteract the M1 dominant status via its reverse signaling behavior. (5) Among 24 intercellular communication exosome mediators, LLSI- and BM- Mφ prefer to use RAB27A and STX3 than RAB31 and YKT6, suggesting new inflammatory exosome mediators for propagating inflammation. (6) Mφ in peritoneal tissue and LLSI-Mφ upregulate higher levels of immunometabolism enzymes than does ATMφ. (7) Mφ from peritoneum and LLSI-Mφ upregulate more trained immunity enzyme genes than does ATMφ. Our results suggest that multiple new mechanisms including the cell surface, intracellular immunometabolism, trained immunity, and TFs may be responsible for disease group-specific and shared pathways. Our findings have provided novel insights on the pathophysiological regulation of tissue Mφ, the disease group-specific and shared pathways of Mφ, and novel therapeutic targets for cancers and inflammations. |
format | Online Article Text |
id | pubmed-6880770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-68807702019-12-10 Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors Lai, Bin Wang, Jiwei Fagenson, Alexander Sun, Yu Saredy, Jason Lu, Yifan Nanayakkara, Gayani Yang, William Y. Yu, Daohai Shao, Ying Drummer, Charles Johnson, Candice Saaoud, Fatma Zhang, Ruijing Yang, Qian Xu, Keman Mastascusa, Kevin Cueto, Ramon Fu, Hangfei Wu, Susu Sun, Lizhe Zhu, Peiqian Qin, Xuebin Yu, Jun Fan, Daping Shen, Ying H. Sun, Jianxin Rogers, Thomas Choi, Eric T. Wang, Hong Yang, Xiaofeng Front Immunol Immunology The mechanisms underlying pathophysiological regulation of tissue macrophage (Mφ) subsets remain poorly understood. From the expression of 207 Mφ genes comprising 31 markers for 10 subsets, 45 transcription factors (TFs), 56 immunometabolism enzymes, 23 trained immunity (innate immune memory) enzymes, and 52 other genes in microarray data, we made the following findings. (1) When 34 inflammation diseases and tumor types were grouped into eight categories, there was differential expression of the 31 Mφ markers and 45 Mφ TFs, highlighted by 12 shared and 20 group-specific disease pathways. (2) Mφ in lung, liver, spleen, and intestine (LLSI-Mφ) express higher M1 Mφ markers than lean adipose tissue Mφ (ATMφ) physiologically. (3) Pro-adipogenic TFs C/EBPα and PPARγ and proinflammatory adipokine leptin upregulate the expression of M1 Mφ markers. (4) Among 10 immune checkpoint receptors (ICRs), LLSI-Mφ and bone marrow (BM) Mφ express higher levels of CD274 (PDL-1) than ATMφ, presumably to counteract the M1 dominant status via its reverse signaling behavior. (5) Among 24 intercellular communication exosome mediators, LLSI- and BM- Mφ prefer to use RAB27A and STX3 than RAB31 and YKT6, suggesting new inflammatory exosome mediators for propagating inflammation. (6) Mφ in peritoneal tissue and LLSI-Mφ upregulate higher levels of immunometabolism enzymes than does ATMφ. (7) Mφ from peritoneum and LLSI-Mφ upregulate more trained immunity enzyme genes than does ATMφ. Our results suggest that multiple new mechanisms including the cell surface, intracellular immunometabolism, trained immunity, and TFs may be responsible for disease group-specific and shared pathways. Our findings have provided novel insights on the pathophysiological regulation of tissue Mφ, the disease group-specific and shared pathways of Mφ, and novel therapeutic targets for cancers and inflammations. Frontiers Media S.A. 2019-11-14 /pmc/articles/PMC6880770/ /pubmed/31824480 http://dx.doi.org/10.3389/fimmu.2019.02612 Text en Copyright © 2019 Lai, Wang, Fagenson, Sun, Saredy, Lu, Nanayakkara, Yang, Yu, Shao, Drummer, Johnson, Saaoud, Zhang, Yang, Xu, Mastascusa, Cueto, Fu, Wu, Sun, Zhu, Qin, Yu, Fan, Shen, Sun, Rogers, Choi, Wang and Yang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Lai, Bin Wang, Jiwei Fagenson, Alexander Sun, Yu Saredy, Jason Lu, Yifan Nanayakkara, Gayani Yang, William Y. Yu, Daohai Shao, Ying Drummer, Charles Johnson, Candice Saaoud, Fatma Zhang, Ruijing Yang, Qian Xu, Keman Mastascusa, Kevin Cueto, Ramon Fu, Hangfei Wu, Susu Sun, Lizhe Zhu, Peiqian Qin, Xuebin Yu, Jun Fan, Daping Shen, Ying H. Sun, Jianxin Rogers, Thomas Choi, Eric T. Wang, Hong Yang, Xiaofeng Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors |
title | Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors |
title_full | Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors |
title_fullStr | Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors |
title_full_unstemmed | Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors |
title_short | Twenty Novel Disease Group-Specific and 12 New Shared Macrophage Pathways in Eight Groups of 34 Diseases Including 24 Inflammatory Organ Diseases and 10 Types of Tumors |
title_sort | twenty novel disease group-specific and 12 new shared macrophage pathways in eight groups of 34 diseases including 24 inflammatory organ diseases and 10 types of tumors |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880770/ https://www.ncbi.nlm.nih.gov/pubmed/31824480 http://dx.doi.org/10.3389/fimmu.2019.02612 |
work_keys_str_mv | AT laibin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT wangjiwei twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT fagensonalexander twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT sunyu twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT saredyjason twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT luyifan twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT nanayakkaragayani twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT yangwilliamy twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT yudaohai twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT shaoying twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT drummercharles twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT johnsoncandice twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT saaoudfatma twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT zhangruijing twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT yangqian twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT xukeman twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT mastascusakevin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT cuetoramon twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT fuhangfei twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT wususu twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT sunlizhe twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT zhupeiqian twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT qinxuebin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT yujun twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT fandaping twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT shenyingh twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT sunjianxin twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT rogersthomas twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT choierict twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT wanghong twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors AT yangxiaofeng twentynoveldiseasegroupspecificand12newsharedmacrophagepathwaysineightgroupsof34diseasesincluding24inflammatoryorgandiseasesand10typesoftumors |